ICLLIndex to Canadian Legal Literature
ICLLInternational Convention on Load Lines
ICLLInternational Center for Limb Lengthening (Baltimore, MD)
ICLLInternational Conference on Lifelong Learning
ICLLIntelligent Coordination and Logistics Laboratory (Carnegie Mellon University; Pittsburgh, PA)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Intercultural language learning (ICLL), however, emphasises the need for learners and users of language to move between languages and cultures, which, in turn, recognises positive aspects of using the first language in language acquisition (Liddicoat, 2008).
This paper investigates a Japanese language subject currently taught at an Australian university, utilising ICLL as the analytical framework.
First and foremost, ICLL places much emphasis on learners' development of intercultural competence.
In terms of pedagogy, ICLL adopts the following five principles:
Liddicoat maintains that noticing is critical in ICLL (Liddicoat, 2002, p.
There are some prior studies to date that have applied the concept of ICLL to Japanese language learning and teaching.
The main objective of this paper is to discuss the appropriateness of translation and interpreting tasks drawing upon the above mentioned framework, ICLL. To this end, firstly, we look into the nature and characteristics of the subject entitled 'Japanese Interpreting and Translation' itself using the same framework.
Intercell is listed on the Vienna stock exchange under the symbol "ICLL" (U.S.
Given new national initiatives, it is likely that IcLL will gain ground as a major focus of language teaching and learning in Australian schools in the next few years.
17 December 2009 - Austrian biotechnology company Intercell AG (WBAG: ICLL) announced on Wednesday promising interim results from a Phase II clinical trial with its vaccine candidate for prevention of infections with the bacterium Pseudomonas aeruginosa.
15 December 2009 - Austrian vaccine developer Intercell AG (WBAG: ICLL) has decided to raise its share capital by EUR845,000 (USD1.2m), the company said today.
11 December 2009 - GlaxoSmithKline Biologicals SA, a unit of UK drug giant GlaxoSmithKline (LON: GSK), has agreed to become a new strategic partner for Intercell AG (WBAG: ICLL) and to acquire up to 5% in the Austrian vaccine developer, the latter said today.